Chloe Gross

1.3k total citations
17 papers, 574 citations indexed

About

Chloe Gross is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Chloe Gross has authored 17 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 9 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Chloe Gross's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (6 papers) and HIV/AIDS drug development and treatment (4 papers). Chloe Gross is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (6 papers) and HIV/AIDS drug development and treatment (4 papers). Chloe Gross collaborates with scholars based in United States and Germany. Chloe Gross's co-authors include Henry Masur, Rachel Silk, Shyam Kottilil, Sarah Kattakuzhy, Elana Rosenthal, Anita Kohli, Gebeyehu Teferi, Anu Osinusi, Amy Nelson and Elizabeth Akoth and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Chloe Gross

17 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloe Gross United States	10	518	467	131	33	31	17	574
Rachel Silk United States	9	555 1.1×	514 1.1×	121 0.9×	34 1.0×	28 0.9×	25	618
Bożena Walewska‐Zielecka Poland	11	380 0.7×	361 0.8×	51 0.4×	14 0.4×	11 0.4×	41	520
Nickolas Kontorinis United States	11	353 0.7×	316 0.7×	108 0.8×	31 0.9×	25 0.8×	21	513
Mina Kabiri United States	9	237 0.5×	239 0.5×	46 0.4×	19 0.6×	15 0.5×	19	356
Philip Vutien United States	15	437 0.8×	438 0.9×	41 0.3×	11 0.3×	12 0.4×	51	573
Maryam Darvishian Canada	14	432 0.8×	434 0.9×	123 0.9×	18 0.5×	9 0.3×	34	562
Antonio Carlotto Italy	7	265 0.5×	324 0.7×	65 0.5×	9 0.3×	21 0.7×	13	360
Marla A. Shu United States	4	355 0.7×	475 1.0×	72 0.5×	19 0.6×	11 0.4×	4	572
G.B. Gaeta Italy	14	355 0.7×	329 0.7×	46 0.4×	11 0.3×	19 0.6×	44	505
Colina Yim Canada	12	567 1.1×	585 1.3×	69 0.5×	5 0.2×	12 0.4×	22	692

Countries citing papers authored by Chloe Gross

Since Specialization

Citations

This map shows the geographic impact of Chloe Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Gross more than expected).

Fields of papers citing papers by Chloe Gross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Gross. The network helps show where Chloe Gross may publish in the future.

Co-authorship network of co-authors of Chloe Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Gross. A scholar is included among the top collaborators of Chloe Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Gross. Chloe Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Silk, Rachel, Chloe Gross, David Sternberg, et al.. (2021). Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. Journal of Addiction Medicine. 16(1). 10–17. 8 indexed citations

Rosenthal, Elana, Rachel Silk, Poonam Mathur, et al.. (2020). Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs. Clinical Infectious Diseases. 71(7). 1715–1722. 82 indexed citations

Wilke, Annika, Hannes Semper, Chloe Gross, & Christian Grohé. (2018). Langzeit-Augmentationstherapie von Patienten mit Alpha-1-Antitrypsin-Mangel in der häuslichen Pflege. Pneumologie. 72(8). 590–597. 2 indexed citations

Chairez, Cheryl, Mary McLaughlin, Rachel Silk, et al.. (2018). Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance. Clinical Infectious Diseases. 69(4). 571–576. 16 indexed citations

Rosenthal, Elana, Poonam Mathur, Chloe Gross, et al.. (2018). Collocation of Buprenorphine with HCV treatment to improve adherence and reduce harm in PWID with HCV: Preliminary data from the ANCHOR study. Journal of Hepatology. 68. S51–S51. 4 indexed citations

Chairez, Cheryl, Mary McLaughlin, Rachel Silk, et al.. (2018). Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV. Antiviral Therapy. 24(6). 451–457. 10 indexed citations

Akoth, Elizabeth, Chloe Gross, Rachel Silk, Elana Rosenthal, & Sarah Kattakuzhy. (2017). A Practical Approach and Model of Care for HCV Treatment With Direct Acting Antivirals in an Urban Setting. Journal of the Association of Nurses in AIDS Care. 28(5). 680–684. 1 indexed citations

Chairez, Cheryl, Elizabeth Akoth, Chloe Gross, et al.. (2017). No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV. The Journal of Infectious Diseases. 217(1). 47–50. 28 indexed citations

Kattakuzhy, Sarah, Chloe Gross, Benjamin Emmanuel, et al.. (2017). Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers. Annals of Internal Medicine. 167(5). 311–318. 166 indexed citations

10.

Gross, Chloe, Elizabeth Akoth, Angie Price, et al.. (2016). HIV/HCV Co-infection: Overcoming Barriers to Treatment. Journal of the Association of Nurses in AIDS Care. 27(4). 524–529. 4 indexed citations

11.

Petersen, Tess, Kerry Townsend, Sreetha Sidharthan, et al.. (2015). High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study. Hepatology International. 10(2). 310–319. 50 indexed citations

12.

Kohli, Anita, Rama Kapoor, Zayani Sims, et al.. (2015). Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. The Lancet Infectious Diseases. 15(9). 1049–1054. 117 indexed citations

13.

Wilson, Eleanor, Sarah Kattakuzhy, Sreetha Sidharthan, et al.. (2015). Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens. Clinical Infectious Diseases. 62(3). 280–288. 38 indexed citations

14.

Townsend, Kerry, Tess Petersen, Anita Kohli, et al.. (2015). Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir. AIDS. 30(2). 261–266. 21 indexed citations

15.

Kattakuzhy, Sarah, Sreetha Sidharthan, Eleanor Wilson, et al.. (2015). P0875 : Predictors of sustained viral response to 4–6 week duration therapy with ledipasvir + sofosbuvir + GS-9451 +/− GS-9669 in early and advanced fibrosis (NIH/UMD synergy trial). Journal of Hepatology. 62. S669–S669. 6 indexed citations

16.

Wilson, Eleanor, Sarah Kattakuzhy, Zayani Sims, et al.. (2015). LP09 : High efficacy of retreatment with ledipasvir and sofosbuvir in HCV patients who failed initial short course therapy with combination DAA regimens (nih synergy trial). Journal of Hepatology. 62. S267–S268. 4 indexed citations

17.

Osinusi, Anu, Kerry Townsend, Amy Nelson, et al.. (2014). O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV. Journal of Hepatology. 60(1). S7–S7. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact